Chemical Compound Review:
Isomeride N-ethyl-1-[3- (trifluoromethyl) phenyl]propa...
Synonyms:
Adipomin, Ponderex, Rotondin, Obedrex, Redux, ...
- Fatal pulmonary hypertension associated with short-term use of fenfluramine and phentermine. Mark, E.J., Patalas, E.D., Chang, H.T., Evans, R.J., Kessler, S.C. N. Engl. J. Med. (1997)
- Valvular heart disease associated with dexfenfluramine. Cannistra, L.B., Davis, S.M., Bauman, A.G. N. Engl. J. Med. (1997)
- An assessment of heart-valve abnormalities in obese patients taking dexfenfluramine, sustained-release dexfenfluramine, or placebo. Sustained-Release Dexfenfluramine Study Group. Weissman, N.J., Tighe, J.F., Gottdiener, J.S., Gwynne, J.T. N. Engl. J. Med. (1998)
- Serotonergic studies in patients with affective and personality disorders. Correlates with suicidal and impulsive aggressive behavior. Coccaro, E.F., Siever, L.J., Klar, H.M., Maurer, G., Cochrane, K., Cooper, T.B., Mohs, R.C., Davis, K.L. Arch. Gen. Psychiatry (1989)
- Serotonergic function in obsessive-compulsive disorder. Behavioral and neuroendocrine responses to oral m-chlorophenylpiperazine and fenfluramine in patients and healthy volunteers. Hollander, E., DeCaria, C.M., Nitescu, A., Gully, R., Suckow, R.F., Cooper, T.B., Gorman, J.M., Klein, D.F., Liebowitz, M.R. Arch. Gen. Psychiatry (1992)
- Controlling panic attacks with fenfluramine. Solyom, L. The American journal of psychiatry. (1994)
- Echocardiographic examination of women previously treated with fenfluramine: long-term follow-up of a randomized, double-blind, placebo-controlled trial. Davidoff, R., McTiernan, A., Constantine, G., Davis, K.D., Balady, G.J., Mendes, L.A., Rudolph, R.E., Bowen, D.J. Arch. Intern. Med. (2001)
- Neuroendocrine evidence that clozapine's serotonergic antagonism is relevant to its efficacy in treating hallucinations and other positive schizophrenic symptoms. Jones, H., Curtis, V.A., Wright, P., Lucey, J.V. The American journal of psychiatry. (1998)
- The prevalence of cardiac valvular insufficiency assessed by transthoracic echocardiography in obese patients treated with appetite-suppressant drugs. Khan, M.A., Herzog, C.A., St Peter, J.V., Hartley, G.G., Madlon-Kay, R., Dick, C.D., Asinger, R.W., Vessey, J.T. N. Engl. J. Med. (1998)
- A population-based study of appetite-suppressant drugs and the risk of cardiac-valve regurgitation. Jick, H., Vasilakis, C., Weinrauch, L.A., Meier, C.R., Jick, S.S., Derby, L.E. N. Engl. J. Med. (1998)
- Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group. Abenhaim, L., Moride, Y., Brenot, F., Rich, S., Benichou, J., Kurz, X., Higenbottam, T., Oakley, C., Wouters, E., Aubier, M., Simonneau, G., Bégaud, B. N. Engl. J. Med. (1996)
- Serotonin depletion by fenfluramine in the carcinoid syndrome. Stahl, S.M., Levin, B. N. Engl. J. Med. (1982)
- Fluoxetine is a safer alternative to fenfluramine in the medical treatment of obesity. Anchors, M. Arch. Intern. Med. (1997)
- Central serotonin activity and aggression: inverse relationship with prolactin response to d-fenfluramine, but not CSF 5-HIAA concentration, in human subjects. Coccaro, E.F., Kavoussi, R.J., Cooper, T.B., Hauger, R.L. The American journal of psychiatry. (1997)
- Prolactin and cortisol responses to fenfluramine in Parkinson's disease. Kostić, V.S., Lecić, D., Doder, M., Marinković, J., Filipović, S. Biol. Psychiatry (1996)
- Redox redux: the control of oxidative stress responses. Demple, B., Amábile-Cuevas, C.F. Cell (1991)
- Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension. Launay, J.M., Hervé, P., Peoc'h, K., Tournois, C., Callebert, J., Nebigil, C.G., Etienne, N., Drouet, L., Humbert, M., Simonneau, G., Maroteaux, L. Nat. Med. (2002)
- Anorexic agents aminorex, fenfluramine, and dexfenfluramine inhibit potassium current in rat pulmonary vascular smooth muscle and cause pulmonary vasoconstriction. Weir, E.K., Reeve, H.L., Huang, J.M., Michelakis, E., Nelson, D.P., Hampl, V., Archer, S.L. Circulation (1996)
- Neurobiology of an anorectic drug: fenfluramine. Rowland, N.E., Carlton, J. Prog. Neurobiol. (1986)
- Absence of fenfluramine-induced anorexia and reduced c-Fos induction in the hypothalamus and central amygdaloid complex of serotonin 1B receptor knock-out mice. Lucas, J.J., Yamamoto, A., Scearce-Levie, K., Saudou, F., Hen, R. J. Neurosci. (1998)
- Life and death in germinal centers (redux). Kelsoe, G. Immunity (1996)
- Myelin repair: developmental myelination redux? Balabanov, R., Popko, B. Nat. Neurosci. (2005)
- Action of fenfluramine on voltage-gated K+ channels in human pulmonary-artery smooth-muscle cells. Wang, J., Juhaszova, M., Conte, J.V., Gaine, S.P., Rubin, L.J., Yuan, J.X. Lancet (1998)
- Relationship between central and peripheral serotonin indexes in depressed and suicidal psychiatric inpatients. Mann, J.J., McBride, P.A., Brown, R.P., Linnoila, M., Leon, A.C., DeMeo, M., Mieczkowski, T., Myers, J.E., Stanley, M. Arch. Gen. Psychiatry (1992)
- Brain-derived neurotrophic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities. Lyons, W.E., Mamounas, L.A., Ricaurte, G.A., Coppola, V., Reid, S.W., Bora, S.H., Wihler, C., Koliatsos, V.E., Tessarollo, L. Proc. Natl. Acad. Sci. U.S.A. (1999)
- Valvular heart disease associated with fenfluramine-phentermine. Connolly, H.M., Crary, J.L., McGoon, M.D., Hensrud, D.D., Edwards, B.S., Edwards, W.D., Schaff, H.V. N. Engl. J. Med. (1997)
- Brain serotonin neurotoxicity and primary pulmonary hypertension from fenfluramine and dexfenfluramine. A systematic review of the evidence. McCann, U.D., Seiden, L.S., Rubin, L.J., Ricaurte, G.A. JAMA (1997)
- Amphetamine and other psychostimulants reduce pH gradients in midbrain dopaminergic neurons and chromaffin granules: a mechanism of action. Sulzer, D., Rayport, S. Neuron (1990)
- Neuroendocrine response to fenfluramine challenge in boys. Associations with aggressive behavior and adverse rearing. Pine, D.S., Coplan, J.D., Wasserman, G.A., Miller, L.S., Fried, J.E., Davies, M., Cooper, T.B., Greenhill, L., Shaffer, D., Parsons, B. Arch. Gen. Psychiatry (1997)
- Effect of d-fenfluramine on basal glucose turnover and fat-feeding-induced insulin resistance in rats. Storlien, L.H., Thorburn, A.W., Smythe, G.A., Jenkins, A.B., Chisholm, D.J., Kraegen, E.W. Diabetes (1989)
- Long-lasting effects of (+/-)3,4-methylenedioxymethamphetamine (ecstasy) on serotonin system function in humans. Gerra, G., Zaimovic, A., Ferri, M., Zambelli, U., Timpano, M., Neri, E., Marzocchi, G.F., Delsignore, R., Brambilla, F. Biol. Psychiatry (2000)
- Hyperphagia Alters Expression of Hypothalamic 5-HT2C and 5-HT1B Receptor Genes and Plasma Des-Acyl Ghrelin Levels in Ay Mice. Nonogaki, K., Nozue, K., Oka, Y. Endocrinology (2006)
- Metabolism of dexfenfluramine in human liver microsomes and by recombinant enzymes: role of CYP2D6 and 1A2. Haritos, V.S., Ching, M.S., Ghabrial, H., Gross, A.S., Taavitsainen, P., Pelkonen, O., Battaglia, S.E., Smallwood, R.A., Ahokas, J.T. Pharmacogenetics (1998)
- Sensitivity to stress-induced reproductive dysfunction linked to activity of the serotonin system. Bethea, C.L., Pau, F.K., Fox, S., Hess, D.L., Berga, S.L., Cameron, J.L. Fertil. Steril. (2005)
- Clinical and echocardiographic follow-up of patients previously treated with dexfenfluramine or phentermine/fenfluramine. Gardin, J.M., Weissman, N.J., Leung, C., Panza, J.A., Fernicola, D., Davis, K.D., Constantine, G.D., Reid, C.L. JAMA (2001)
- Valvular abnormalities and cardiovascular status following exposure to dexfenfluramine or phentermine/fenfluramine. Gardin, J.M., Schumacher, D., Constantine, G., Davis, K.D., Leung, C., Reid, C.L. JAMA (2000)
- International trial of long-term dexfenfluramine in obesity. Guy-Grand, B., Apfelbaum, M., Crepaldi, G., Gries, A., Lefebvre, P., Turner, P. Lancet (1989)